查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1632614

全球临床实验试验生物库和檔案解决方案市场：市场规模、份额和趋势分析（按服务、产品、阶段、地区和细分市场，2025-2030 年）

Clinical Trial Biorepository & Archiving Solutions Market Size, Share & Trends Analysis Report By Service (Biorepository Services, Archiving Solution Services), By Product, By Phase, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 192 Pages | 商品交期: 2-10个工作天内

价格

临床实验生物库和檔案解决方案市场的成长和趋势：

根据Grand View Research, Inc.的最新报告，全球临床实验试验生物库和檔案解决方案市场规模预计到2030年将达到70.1亿美元，2025年至2030年期间的复合年增长率为8.18%。

这主要是因为生物样本管理在临床实验试验中的重要性日益增加，以及简化资料收集和报告的意愿。此外，精准医疗、个人化医疗和基因组医学的扩展、研发支出的增加、以及透过采用 LIMS（实验室资讯管理系统）等软体进行实验室样本管理以促进资料收集和报告的努力都是推动该行业成长的关键因素。

一些监管机构为生物样本库的运作提供了建议并制定了最佳实践。国际生物和环境檔案协会正在加强其在全球范围内标准化生物檔案程序方面的地位。美国病理学家学院建立了第一个生物样本库设施认证计划，该计划遵守严格的规定，以规范生物样本库设施的实践。国际标准化组织（ISO-20387）发布了生物保存设施标准，以确保生物保存能力、公平性和一致性运作。

美国FDA制定了良好生产规范（GMP）、良好实验室规范（GLP）、GDP、良好组织规范（GTP），其中包含了与药品包装和储存相关的要素。此外，新冠疫情也为当地企业创造了许多成长机会。为了在行业中站稳脚跟，主要企业正在采取各种计划和政策，以在全球市场上抢占更大的收益占有率。作为重要一步，主要企业可以与相关的第三方供应商建立合作关係。这可以透过适当的沟通和协调临床实验试验生物库和归檔解决方案的频率和数量来实现。

临床实验生物库和檔案解决方案市场：分析概述

  • 2024 年，生物检体资料库服务部门将占据市场主导地位，占 66.91% 的收益占有率。该领域的成长主要得益于再生医学、个人化医疗和癌症基因组学研究等先进疗法的研究和开发不断增加，这些疗法需要有效的储存、分配和处理解决方案。
  • 根据产品，市场分为临床前产品和临床产品。 2024 年，临床产品部门在临床实验生物库和檔案解决方案市场中占据最大收益占有率，为 63.40%。
  • 依阶段，市场分为临床前、第一阶段、第二阶段、第三阶段、第四阶段。临床前部分在 2024 年占据最大的收益占有率，为 36.60%。该领域的成长可归因于对资料完整性和透明度的日益重视。
  • 2024 年北美临床实验生物库和檔案解决方案市场占有最大份额，为 47.99%。临床试验数量的不断增加以及希望扩展现有服务的众多市场参与者进一步促进了临床实验试验生物库和归檔解决方案的成长。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章临床实验生物库和檔案解决方案市场：驱动因素、趋势和范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 临床实验生物库和檔案解决方案市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第 4 章临床实验生物库和檔案解决方案市场：按服务进行的估计和趋势分析

  • 全球临床实验试验生物库和檔案解决方案市场：细分仪表板（按服务划分）
  • 全球临床实验试验生物库和檔案解决方案市场：按服务进行变化分析
  • 依服务分类（2018-2030 年）
  • 生物检体资料库服务
    • 生物检体资料库服务市场（2018-2030）
    • 仓库存放
    • 送货
    • 样品处理
    • 其他的
  • 归檔解决方案服务
    • 檔案解决方案服务市场（2018-2030）
    • 资料库索引的建立和管理
    • 扫描并销毁

第 5 章临床实验生物库和檔案解决方案市场：按产品分類的估计和趋势分析

  • 全球临床实验试验生物库和檔案解决方案市场：细分仪表板（按产品划分）
  • 全球临床实验试验生物库和檔案解决方案市场：按产品进行变化分析
  • 按产品（2018 - 2030 年）
  • 临床前产品
    • 临床前产品市场（2018-2030）
  • 临床产品
    • 临床产品市场（2018-2030）
    • 人体组织
    • 器官
    • 干细胞
    • 其他生物检体

第六章临床实验生物库和檔案解决方案市场：各阶段的估计和趋势分析

  • 全球临床实验试验生物库和檔案解决方案市场：细分仪表板，按阶段划分
  • 全球临床实验生物库和檔案解决方案市场：按阶段进行数量分析
  • 阶段（2018-2030）
  • 临床前
    • 临床前市场（2018-2030）
  • 第一阶段
    • 第一阶段市场（2018-2030年）
  • 第二阶段
    • 第二阶段市场（2018-2030年）
  • 第三阶段
    • 第三阶段市场（2018-2030年）
  • 第四阶段
    • 第四阶段市场（2018-2030年）

第 7 章临床实验生物库和檔案解决方案市场：区域估计和趋势分析

  • 按地区分類的市场占有率分析（2024 年和 2030 年）
  • 市场仪表板：按地区
  • 全球市场概况：按地区
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
  • 公司市场占有率分析（2023/24）
  • 公司简介
    • Medpace
    • American Type Culture Collection (ATCC)
    • Cell&Co BioServices (Cryoport)
    • Brooks Life Sciences (Azenta, Inc.)
    • Patheon (Thermo Fisher Scientific, Inc.)
    • Precision Medicine Group, LLC.
    • Labcorp Drug Development
    • Q2 Solutions
    • LabConnect
    • Charles River Laboratories

第九章 主要建议

Product Code: GVR-4-68039-532-8

Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends:

The global clinical trial biorepository & archiving solutions market size is expected to reach USD 7.01 billion by 2030, registering a CAGR of 8.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.

Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).

The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.

Clinical Trial Biorepository & Archiving Solutions Market Report Highlights:

  • In 2024, the biorepository services segment dominated the market, accounting for a revenue share of 66.91%. The segment growth can be attributed to the rise in R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, which require effective storage, distribution, and processing solutions.
  • On the basis of the product segment, the market is segmented into preclinical products and clinical products. In 2024, the clinical products segment accounted for the largest revenue share of 63.40% in the clinical trial biorepository & archiving solutions market.
  • On the basis of phase segment, the market is segmented to preclinical, phase I, phase II, phase III, and phase IV. The preclinical segment accounted for the largest revenue share of 36.60% in 2024. The segment growth can be growing emphasis on data integrity & transparency.
  • North America clinical trial biorepository & archiving solutions market accounted for the largest share of 47.99% in 2024. The increase in the number of clinical trials and several market players in the region aiming to expand their existing services are further contributing to the growth of clinical trial biorepository & archiving solutions.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Product
    • 1.2.3. Phase
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trial Biorepository & Archiving Solutions Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing number of pharmaceutical and biotechnology companies
      • 3.2.1.2. Growing disease variation and prevalence
      • 3.2.1.3. Increasing R&D investments
      • 3.2.1.4. Growth in the CRO market
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulations for new drug development
      • 3.2.2.2. Rising cost of clinical trials
  • 3.3. Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Biorepository & Archiving Solutions Market: Service Estimates & Trend Analysis

  • 4.1. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Segment Dashboard
  • 4.2. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Movement Analysis
  • 4.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Service, 2018 - 2030
  • 4.4. Biorepository Services
    • 4.4.1. Biorepository Services Market, 2018 to 2030 (USD Million)
    • 4.4.2. Warehousing & Storage
      • 4.4.2.1. Warehousing & Storage Market, 2018 to 2030 (USD Million)
    • 4.4.3. Transportation
      • 4.4.3.1. Transportation Market, 2018 to 2030 (USD Million)
    • 4.4.4. Sample Processing
      • 4.4.4.1. Sample Processing Market, 2018 to 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market, 2018 to 2030 (USD Million)
  • 4.5. Archiving Solution Services
    • 4.5.1. Archiving Solution Services Market, 2018 to 2030 (USD Million)
    • 4.5.2. Database Indexing and Management
      • 4.5.2.1. Database Indexing and Management Market, 2018 to 2030 (USD Million)
    • 4.5.3. Scanning & Destruction
      • 4.5.3.1. Scanning & Destruction Market, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Biorepository & Archiving Solutions Market: Product Estimates & Trend Analysis

  • 5.1. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Segment Dashboard
  • 5.2. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Movement Analysis
  • 5.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Product, 2018 - 2030
  • 5.4. Preclinical Products
    • 5.4.1. Preclinical Products Market, 2018 to 2030 (USD Million)
  • 5.5. Clinical Products
    • 5.5.1. Clinical Products Market, 2018 to 2030 (USD Million)
    • 5.5.2. Human Tissue
      • 5.5.2.1. Human Tissue Market, 2018 to 2030 (USD Million)
    • 5.5.3. Organs
      • 5.5.3.1. Organs Market, 2018 to 2030 (USD Million)
    • 5.5.4. Stem Cells
      • 5.5.4.1. Stem Cells Market, 2018 to 2030 (USD Million)
    • 5.5.5. Other Biospecimens
      • 5.5.5.1. Other Biospecimens Market, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Biorepository & Archiving Solutions Market: Phase Estimates & Trend Analysis

  • 6.1. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Segment Dashboard
  • 6.2. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Movement Analysis
  • 6.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Phase, 2018 - 2030
  • 6.4. Preclinical
    • 6.4.1. Preclinical conditions Market, 2018 to 2030 (USD Million)
  • 6.5. Phase I
    • 6.5.1. Phase I Market, 2018 to 2030 (USD Million)
  • 6.6. Phase II
    • 6.6.1. Phase II Market, 2018 to 2030 (USD Million)
  • 6.7. Phase III
    • 6.7.1. Phase III Market, 2018 to 2030 (USD Million)
  • 6.8. Phase IV
    • 6.8.1. Phase IV Market, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Biorepository & Archiving Solutions Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share Analysis, 2023/24
  • 8.3. Company Profiles
    • 8.3.1. Medpace
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. American Type Culture Collection (ATCC)
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Cell&Co BioServices (Cryoport)
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Brooks Life Sciences (Azenta, Inc.)
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Patheon (Thermo Fisher Scientific, Inc.)
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Precision Medicine Group, LLC.
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Labcorp Drug Development
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Q2 Solutions
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. LabConnect
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Charles River Laboratories
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives

Chapter 9 Key Recommendations

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 5 North America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 6 North America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 7 U.S. Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 8 U.S. Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 10 Canada Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 11 Canada Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 13 Mexico Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 14 Mexico Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 15 Mexico Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 16 Europe Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 17 Europe Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 18 Europe Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 19 Europe Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 20 UK Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 21 UK Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 22 UK Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 23 Germany Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 24 Germany Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 25 Germany Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 26 France Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 27 France Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 28 France Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 29 Italy Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 30 Italy Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 31 Italy Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 32 Spain Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 33 Spain Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 34 Spain Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 35 Denmark Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 36 Denmark Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 37 Denmark Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 38 Sweden Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 39 Sweden Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 40 Sweden Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 41 Norway Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 42 Norway Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 43 Norway Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 48 Japan Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 49 Japan Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 50 Japan Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 51 China Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 52 China Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 53 China Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 54 India Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 55 India Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 56 India Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 57 Australia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 58 Australia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 59 Australia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 60 South Korea Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 61 South Korea Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 62 South Korea Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 63 Thailand Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 64 Thailand Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 65 Thailand Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 66 Latin America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 67 Latin America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 68 Latin America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 69 Latin America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 70 Brazil Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 71 Brazil Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 72 Brazil Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 73 Argentina Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 74 Argentina Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 75 Argentina Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 76 Colombia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 77 Colombia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 78 Colombia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 83 South Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 84 South Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 85 South Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 89 UAE Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 90 UAE Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Clinical trial biorepository & archiving solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot 1
  • Fig. 13 Segment snapshot 2
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Parent market outlook, 2023 (USD Billion)
  • Fig. 16 Ancillary market outlook, 2023 (USD Billion)
  • Fig. 17 Clinical trial biorepository & archiving solutions market dynamics
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 PESTEL analysis
  • Fig. 20 Clinical trial biorepository & archiving solutions market: Service outlook and key takeaways
  • Fig. 21 Clinical Trial Biorepository & Archiving Solutions market: Service movement analysis
  • Fig. 22 Biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Warehousing & storage market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Transportation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sample processing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Others biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Archiving solution services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Database indexing & management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Scanning & destruction market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Clinical Trial Biorepository & Archiving Solutions market: Product outlook and key takeaways
  • Fig. 31 Clinical Trial Biorepository & Archiving Solutions market: Product movement analysis
  • Fig. 32 Preclinical products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Clinical products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Human tissue market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Organs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Stem cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Other biospecimens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Clinical Trial biorepository & archiving solutions market: Phase outlook and key takeaways
  • Fig. 39 Clinical trial biorepository & archiving solutions market: Phase movement analysis
  • Fig. 40 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Phase I market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Phase II market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Phase III market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Phase IV market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 North America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Europe clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 UK clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Sweden clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Norway clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Asia Pacific clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 China clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 India clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Japan clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Australia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Latin America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Colombia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 MEA clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Africa clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Fig. Key country dynamics
  • Fig. 94 Saudi Arabia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 UAE clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Kuwait clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key company categorization
  • Fig. 100 Service heat map analysis
  • Fig. 101 Strategic framework